MetLife Investment Management’s Zynex ZYXI Stock Holding History

MetLife Investment Management’s Portfolio ZYXI Stock Details ZYXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-13,150	Closed	-$123K	–	2897
2024 Q2	$123K	Buy	13,150 +1,205	+10%	+$12.8K	﹤0.01%	2501
2024 Q1	$148K	Hold	11,945	–	–	﹤0.01%	2352
2023 Q4	$130K	Hold	11,945	–	–	﹤0.01%	2475
2023 Q3	$95.6K	Hold	11,945	–	–	﹤0.01%	2603
2023 Q2	$115K	Hold	11,945	–	–	﹤0.01%	2593
2023 Q1	$143K	Hold	11,945	–	–	﹤0.01%	2400
2022 Q4	$166K	Hold	11,945	–	–	﹤0.01%	2363
2022 Q3	$108K	Buy	+11,945	New	+$104K	﹤0.01%	2644
2021 Q4	–	Sell	-8,281	Closed	-$85.7K	–	2558
2021 Q3	$85.7K	Buy	+8,281	New	+$106K	﹤0.01%	2493
2020 Q4	–	Sell	-8,883	Closed	-$141K	–	2320
2020 Q3	$141K	Hold	8,883	–	–	﹤0.01%	2060
2020 Q2	$201K	Hold	8,883	–	–	﹤0.01%	1906
2020 Q1	$89.4K	Buy	+8,883	New	+$86.4K	﹤0.01%	2132

Other funds holding ZYXI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BCC

Bridge City Capital Lake Oswego, Oregon $438M AUM 64.84% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

MetLife Investment Management's ZYXI Position: Q3 2024 in Review

MetLife Investment Management sold out of Zynex (ZYXI) in Q3 2024, closing a stake of 13,150 shares — an estimated $123K sold.

MetLife Investment Management first reported a position in ZYXI in Q1 2020 and held it in 12 quarters. The position peaked at $201K in Q2 2020. 101 funds tracked by Wall St. Rank hold ZYXI as of Q3 2024.

MetLife Investment Management reported no remaining Zynex position as of Q3 2024 after selling out during the quarter.
MetLife Investment Management sold 13,150 Zynex shares in Q3 2024, an estimated $123K.
MetLife Investment Management first reported a position in Zynex in Q1 2020 and held it in 12 quarters.
MetLife Investment Management's Zynex position peaked at $201K in Q2 2020.
101 funds tracked by Wall St. Rank held Zynex as of Q3 2024.

Based on MetLife Investment Management's 13F filing for Q3 2024, filed 13 Nov 2024.